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P2X7 receptors have received special attention in the literature
for their involvement in several diseases characterized by
inflammatory processes such as cancer, arthritis, neurodegen-
erative pathologies and chronic pains.1 The P2X7 receptor is an
adenosine 5′-triphosphate (ATP)-gated non-selective cation
channel and its activation mediates the depolarization of an
inward current due to a major influx of Na+ and Ca2+ into the
cytosol, while a concomitant efflux of K+ is generated.2 The
binding of ATP to the P2X7 receptors is tightly regulated by
allosteric mechanisms that act either on their extracellular or on
their intracellular/transmembrane domains.3 In our recently
published manuscript in Cell Death Discovery,4 it was proposed
that the cell surface glycosaminoglycan (GAG) chains fromCD44
proteoglycanshavea relevant functional impact onP2X7-receptor
physiology, emerging as a new cofactor that is necessary for the
full receptor activity and a new post-translational regulatory
mechanism for purinergic signaling at the cellular level.4
We have shown that GAGs from the cell surface bind to the
P2X7 receptor and facilitate the binding of ATP to the ligand-
gated cation channel. The presence of GAGs at CHO cell
surface greatly increases sensitivity to low concentrations of
ATPand changes themain P2X7 kinetic parameters EC50, Hill
coefficient and Emax. Yet, in the absence of ATP, even the
highest heparin concentration tested did not elicit a noticeable
P2X7 activation. Furthermore, the allosteric block of P2X7
receptor current by extracellular Mg2+ ion weremitigated when
GAGs are present. Our data argue for an allosteric sensitiza-
tion of the receptor by GAGs. In addition, the formation,
recruitment and the P2X7 pore dilation augmented in the
presence of GAGs as demonstrated by the acceleration of
cellular uptake of large molecules such as propidium iodide
(MW 668 Da) and by the molecular dynamic simulations.
Increase in Emax of Ca2+ influx and acceleration of propidium
iodide influx confirmed the potentiating effect of GAGs on
native P2X7 receptors. Consequently, wild-type CHO-K1 cells
were more sensitive to cell death induced by P2X7 agonists
than its mutant CHO-745, defective in GAG biosynthesis.4
The ability of P2X7 to respond to a wide range of ATP
concentrations reflects ATP binding to its three binding sites
on the trimeric receptor of negative cooperativity, where partial
ATP occupancy results in the opening of an intrinsic non-
selective pore for small mono- and divalent cations, including
Ca2+. On the other hand, full occupancy at high ATP
concentrations triggers the pore dilation. Thus, the rate and
extent of P2X7 sensitization determine the outcome of the
receptor activation.5 We identified cell surface GAGs as key
regulators of P2X7 receptor sensitization and pore dilation.
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Our data support a model in which GAG binding might
overcome the conformational hindrances under conditions of
partial agonist occupancy and thereby promote the long
opening–gating mode (Figure 1).
Using confocal microscopy experiments, we have shown
that P2X7 receptors co-localize with CD44 proteoglycans on
the wild-type CHO-K1 cell surface, but not in the CHO-745 cell
line. Moreover, we used immunoprecipitation followed by
immunoblotting approaches to provide a direct biochemical
evidence for physical association between soluble CD44
ectodomain (sCD44) and P2X7 receptor. CD44 proteoglycans
are involved in awide spectrum of physiological functions such
as cell–cell and cell–matrix interactions, morphogenesis, cell
migration, cellular differentiation and tumorigenic process.6
Also, it is important to mention that CD44 proteolytic cleavage
products, sCD44 and CD44-ICD, serve as tumorigenic factors
by enhancing cell proliferation/migration.7 Interestingly, ATP-
mediated cytoplasmic Ca2+ influx by P2X7 receptors results in
the CD44 ectodomain proteolytic shedding forming sCD44
products8 via P2X7 receptor stimulation of disintegrin and
metalloproteinase-10 (ADAM10)-dependent proteolytic activity.9
CD44 proteoglycans and P2X7 receptors are involved
in oncogenic processes and most malignant tumors do
overexpress them. Tumorigenic cells overexpressing P2X7
receptors show enhanced engraftment ability and in vivo
growth rate, enhanced invasiveness, increased expression of
proliferation markers, reduced apoptosis and angiogenesis.10
Seemingly, CD44 overexpression is essential for the
anchorage-independent growth, tumor growth and tumor-
initiating ability of highly tumorigenic mammary epithelial
cells.11 Our study suggests GAG chains from sCD44 as a
hitherto physiological positive allosteric modulator of P2X7
receptor, where sCD44 is part of a regulatory positive feedback
loop linking P2X7 receptor activation, which allows the
intracellular responsemediated by ATP cell signaling (Figure 1).
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Ultimately, our study has several implications: (1) the
presence of GAGs on the cell surface controls the rate of
P2X7 sensitization and determines the outcome of receptor
activation, whereas the absence of the GAGs at cell surface
results in a hypo-functional P2X7 receptor with reduced
agonist sensitivity; (2) the regulation of CD44 proteogly-
cansʼ/GAGsʼ fine structure may provide a mechanism for the
cellular control of P2X7 activation; (3) an effective antagonist in
an in vitro model may not serve for human therapeutic use if
GAGs are used as the physiological positive allosteric
modulator of P2X7 receptors, hence caution should be taken
when investigating the pharmacological blockade of P2X7 in
both in vitro and in vivo studies; (4) the activity of P2X7
receptorsmay be spatially and temporally coordinated with the
CD44 proteoglycan expression in different cellular models and
in various pathophysiological states (Figure 1).
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Figure 1 GAG chains from CD44 proteoglycan are a physiological positive allosteric modulator of P2X7 receptor. P2X7 stimulation on the surface of CHO cells is dependent
on the extracellular concentration of ATP and P2X7 density, and expression of CD44 proteoglycan is dependent on their activation status. ATP-mediated P2X7 activation increases
the cytoplasmic level of Ca2+, a universal second messenger. Ca2+ influx by P2X7 receptors results in the ectodomain proteolytic shedding of CD44 by activation of proteolytic
enzymes, ADAM10 and presenilin-γ-secretase, forming as products sCD44 and CD44-ICD, respectively. CD44-ICD translocates to the nucleus and activates gene transcription.
(a) The absence of the GAG chains from CD44 proteoglycan on the cell surface resulted in a hypo-functional P2X7 receptor with reduced agonist sensitivity. (b) GAG chains from
CD44 are a positive allosteric modulator of P2X7 receptor; where sCD44 is part of a regulatory positive feedback loop linking P2X7 receptor activation and thereby allows the
intracellular response mediated by ATP cell signaling. (c) The activity of P2X7 receptors may be spatially and temporally coordinated with the CD44 proteoglycan expression in
different cellular models and in various pathophysiological states. CD44 proteoglycans and P2X7 receptors are involved in oncogenic processes; most malignant tumors
overexpress P2X7 and CD44 receptors. CD44 proteolytic cleavage products, sCD44 and CD44-ICD, serve a tumorigenic process by enhancing the proliferation/migration of cells
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